405 related articles for article (PubMed ID: 18006841)
1. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
2. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
3. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
4. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
[TBL] [Abstract][Full Text] [Related]
5. Anti-neovascular therapy using novel peptides homing to angiogenic vessels.
Oku N; Asai T; Watanabe K; Kuromi K; Nagatsuka M; Kurohane K; Kikkawa H; Ogino K; Tanaka M; Ishikawa D; Tsukada H; Momose M; Nakayama J; Taki T
Oncogene; 2002 Apr; 21(17):2662-9. PubMed ID: 11965539
[TBL] [Abstract][Full Text] [Related]
6. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
7. A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.
Lee TY; Wu HC; Tseng YL; Lin CT
Cancer Res; 2004 Nov; 64(21):8002-8. PubMed ID: 15520208
[TBL] [Abstract][Full Text] [Related]
8. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
[TBL] [Abstract][Full Text] [Related]
9. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
Li Y; Lei Y; Wagner E; Xie C; Lu W; Zhu J; Shen J; Wang J; Liu M
Bioconjug Chem; 2013 Jan; 24(1):133-43. PubMed ID: 23241015
[TBL] [Abstract][Full Text] [Related]
10. Vascular targeting with phage peptide libraries.
Pasqualini R
Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
[TBL] [Abstract][Full Text] [Related]
11. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
12. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
14. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
Sochanik A; Mitrus I; Smolarczyk R; CichoĊ T; Snietura M; Czaja M; Szala S
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
[TBL] [Abstract][Full Text] [Related]
15. Identification of one vasculature specific phage-displayed peptide in human colon cancer.
Zhao X; Hu J; Huang R; Yang L
J Exp Clin Cancer Res; 2007 Dec; 26(4):509-14. PubMed ID: 18365546
[TBL] [Abstract][Full Text] [Related]
16. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
17. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.
Curnis F; Sacchi A; Corti A
J Clin Invest; 2002 Aug; 110(4):475-82. PubMed ID: 12189241
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific delivery of a chemotherapeutic to lung cancer cells.
Zhou X; Chang YC; Oyama T; McGuire MJ; Brown KC
J Am Chem Soc; 2004 Dec; 126(48):15656-7. PubMed ID: 15571383
[TBL] [Abstract][Full Text] [Related]
19. Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs.
Corti A; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():104-12. PubMed ID: 15650236
[TBL] [Abstract][Full Text] [Related]
20. Identification of synovium-specific homing peptides by in vivo phage display selection.
Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]